MedTrace Logo

Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis

NCT05132192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 335

Last updated 2021-11-24

No results posted yet for this study

Summary

Data of demographic, clinical, laboratory and imaging studies of living donor liver transplantation (LDLT) recipients from two transplant centers were collected. Survival and morbidity rates between patients with and without portal vein thrombosis (PVT) were compared. Risk factors of mortality in the setting of PVT were identified. Intraoperative portal flow measurements were compared before and after portal flow restoration.

Conditions

  • Portal Vein Thrombosis
  • Liver Transplant; Complications

Interventions

PROCEDURE

living donor liver transplantation

Living donor liver transplantation

PROCEDURE

Thrombectomy or interposition graft

Portal flow restoration due to PVT in any manner

Sponsors & Collaborators

  • Ankara University

    collaborator OTHER

  • Ankara Guven Hospital

    collaborator UNKNOWN

  • Elvan Onur Kirimker

    lead OTHER

Principal Investigators

  • Elvan O Kirimker, MD · Ankara University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2020-07-30
Completion
2020-10-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05132192 on ClinicalTrials.gov